Clinically relevant drug interactions with new generation antidepressants and antipsychotics;Spezielle arzneimittelinteraktionen

Therapeutische Umschau

Volumn 66, Issue 6, 2009, Pages 485-492

  Eckert, Anne ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AGOMELATINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOMIPRAMINE; CLOZAPINE; CYTOCHROME P450; DESIPRAMINE; DIAZEPAM; DULOXETINE; ELONTRIL; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; LITHIUM; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; NORFLUOXETINE; PALIPERIDONE; PAROXETINE; PHENYTOIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VENLAFAXINE;

AREA UNDER THE CURVE; CLINICAL PRACTICE; DEPRESSION; DRUG INTERACTION; DRUG MECHANISM; DRUG METABOLISM; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; GENETIC POLYMORPHISM; HUMAN; LIVER METABOLISM; MENTAL DISEASE; REVIEW; SEROTONIN SYNDROME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DEPRESSIVE DISORDER; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; ENZYME INDUCTION; HUMANS; ISOENZYMES; LIVER; METABOLIC CLEARANCE RATE; PSYCHOTIC DISORDERS;

EID: 66949149561     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.66.6.485     Document Type: Review

References (7)

1. Eckert A, Reiff J, Müller WE. Arzneimittelinteraktionen mit Antidepressiva. Vorteile des spezifischen Seretonin-Wiederaufnahmehemmers Citalopram. Psychopharmakotherapie 1998; 5: 8-18.
2. Benkert O, Hippius H. eds. Kompendium der psychiatrischen Pharmakotherapie, Springer, Berlin Heidelberg New York Tokio, 2007.
3. Eckert A, Müller WE. Pharmakologische Grundlagen. In: Holsboer, Gründer, Benkert, eds. Handbuch der Psychopharmakotherapie, Springer Medizin Verlag Heidelberg, 2008: 29-42.
4. Hiemke C. Arzneimittelinteraktionen. In: Schneider, Niebling, eds. Psychische Erkrankungen in der Hausarztpraxis, Springer Berlin Heidelberg, 2008: 127-136.
5. Hiemke C, Baumann P, Laux G, Kuss HJ. Therapeutisches Drug-Monitoring in der Psychiatrie. Psychopharmakotherapie 2005;12: 166-182.
6. Müller, W.E., Eckert, A. Psychopharmakotherapie: Pharmakologische Grundlagen. In: H.-J. Möller, G. Laux and H.-P Kapfhammer, eds. Psychiatrie und Psychotherapie, Springer-Verlag Berlin, Heidelberg, New York, 3. Auflage, 2008:583-626.
7. Spina E, Santoro V, D'Arrigo C. Clinically relevant pharmacokinetic drug interactions with second-generation antidepressants: an update. Clin Ther 2008; 30: 1206-1227